Polyglandular autoimmune syndromes

European Journal of Endocrinology

Volumn 161, Issue 1, 2009, Pages 11-20

  Kahaly, George J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOIMMUNE REGULATOR PROTEIN; CORTISONE ACETATE; DEOXYRIBONUCLEASE I; HLA ANTIGEN; HYDROCORTISONE; LEVOTHYROXINE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; T LYMPHOCYTE ANTIGEN;

ANTIBODY SPECIFICITY; AUTOIMMUNE POLYENDOCRINOPATHY; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME 1; CHROMOSOME 2; CHROMOSOME 21; CHROMOSOME 6; CLINICAL FEATURE; DISEASE CLASSIFICATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FUNCTION TEST; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MUTATIONAL ANALYSIS; NONHUMAN; ONSET AGE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEROLOGY; ANIMAL; AUTOIMMUNITY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; RISK FACTOR;

ANIMALS; AUTOIMMUNITY; CHROMOSOMES, HUMAN, PAIR 21; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYENDOCRINOPATHIES, AUTOIMMUNE; RISK FACTORS;

EID: 67650770693     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0044     Document Type: Review

References (74)

1. Eisenbarth GS & Gottlieb PA. Autoimmune polyendocrine syndromes. New England Journal of Medicine 2004 350 2068-2079.
2. Neufeld M, MacLaren N & Blizzard R. Autoimmune polyglandular syndromes. Pediatric Annals 1980 9 154-162.
3. Jenkins RC & Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid 2002 12 977-988.
4. Betterle C, Greggio NA & Volpato M. Clinical review 93: autoimmune polyglandular syndrome type 1. Journal of Clinical Endocrinology and Metabolism 1998 83 1049-1055.
5. Obermayer-Straub P, Strassburg CP & Manns MP. Autoimmune polyglandular syndrome type 1. Clinical Reviews in Allergy and Immunology 2000 18 167-183.
6. Ten S, New M & MacLaren N. Clinical review 130: Addison's disease 2001. Journal of Clinical Endocrinology and Metabolism 2000 86 2909-2922.
7. Förster G, Krummenauer F, Kühn I, Beyer J & Kahaly G. Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation. Deutsche Medizinische Wochenschrift 1999 124 1476-1481.
8. Zhu J & Paul WE. CD4 T cells: fates, functions, and faults. Blood 2008 112 1557-1569.
9. Martinez GJ, Nurieva RI, Yang XO & Dong C. Regulation and function orf proinflammatory TH17 cells. Annals of the New York Academy of Sciences 2008 1143 188-211.
10. Anderson MS. Autoimmune endocrine diseases. Current Opinion in Immunology 2002 14 760-764.
11. Devendra D & Eisenbarth GS. Immunologic endocrine disorders. Journal of Allergy and Clinical Immunology 2003 111 S624-S636.
12. Topliss D, How J, Lewis M, Row V & Volpe R. Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1983 57 700-705.
13. Canbay A, Gieseler R, Ella R, Fink H, Saller B & Mann K. Manifestation of adrenal insufficiency after administration of levothyroxine in a patient with polyglandular autoimmune syndrome type II (Schmidt-syndrome). Internist 2000 41 588-591.
14. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology 2004 22 531-562.
15. Shevach EM. Regulatory T cells in autoimmmunity. Annual Review of Immunology 2000 18 423-449.
16. Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR & Lorenz HM. Defective suppressor function of human CD4+ CD25+ regulatory Tcells in autoimmune polyglandular syndrome type II. Journal of Experimental Medicine 2004 199 1285-1291.
17. Luther C, Poeschel S, Varga M, Melms A & Tolosa E. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia - associated thymoma. Journal of Neuroimmunology 2005 164 124-128.
18. Viglietta V, Baecher-Allan C, Weiner HL & Hafler DA. Loss of functional suppression by CD4+CD25+regulatory T cells in patients with multiple sclerosis. Journal of Experimental Medicine 2004 199 971-979.
19. Sakaguchi S, Sakaguchi N, Asano M, Itoh M & Toda M. Immunologic self-tolerance maintained by activated T cells expression IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 1995 155 1151-1164.
20. Lan RY, Ansari AA, Lian ZX & Gershwin ME. Regulatory T cells: development, function and role in autoimmunity. Autoimmunity Reviews 2005 4 351-363.
21. Dittmar M, Poppe R, Bischofs C, Fredenhagen G, Kanitz M & Kahaly GJ. Impaired deoxyribonuclease activity in monoglandular and polyglandular autoimmunity. Experimental and Clinical Endocrinology and Diabetes 2007 115 387-391.
22. Dittmar M, Bischofs C, Matheis N, Poppe R & Kahaly GJ. A novel mutation in the DNAse I gene is related with protein instability and decreased enzyme activity in thyroid autoimmunity. Journal of Autoimmunity 2009 32 7-13.
23. Rock FL, Hardiman G, Timans JC, Kastelein RA & Bazan JF. A family of human receptors structurally related to Drosophila Toll. PNAS 1998 95 588-593.
24. Chuang T & Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochimica et Biophysica Acta 2001 1518 157-161.
25. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Schlomchik MJ & Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002 416 603-607.
26. Gianani R & Sarvetnick N. Viruses, cytokines, antigens, and autoimmunity. PNAS 1996 93 2257-2259.
27. Wallaschofski H, Meyer A, Tuschy U & Lohmann T. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Hormone and Metabolic Research 2003 35 120-124.
28. Robles DT, Fain PR, Gottlieb PA & Eisenbarth GS. The genetics of autoimmune polyendocrine syndrome type II. Endocrinology and Metabolism Clinics of North America 2002 31 353-368.
29. Eisenbarth GS, Wilson P, Ward F & Lebovita H. HLA type and occurrence of disease in familial polyglandular failure. New England Journal of Medicine 1978 298 92-94.
30. Tisch R & McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996 85 291-297.
31. Sanjeevi CB, Lybrand TP, DeWeese C, Landin-Olsson M, Kockum I, Dahlquist G, Sundkvist G, Stenger D & Lernmark A. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study. Diabetes 1995 44 125-131.
32. Tandon N, Zhang L & Weetman AP. HLA associations with Hashimoto's thyroiditis. Clinical Endocrinology 1991 34 383-386.
33. Roman SH, Greenberg D, Rubinstein P, Wallenstein S & Davies TF. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. Journal of Clinical Endocrinology and Metabolism 1992 74 496-503.
34. Tomer Y, Barbesino G, Greenberg DA, Concepcion E & Davies TF. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. Journal of Clinical Endocrinology and Metabolism 1999 84 4656-4664.
35. Dittmar M, Kaczmarzyk A, Bischofs C & Kahaly GJ. The proinflammatory cytokine TNFalpha 308 genotype is associated with polyglandular autoimmunity. Immunological Investigations 2009 38 1-13.
36. Moghaddam PH, Zwinderman AH, de Knijff P, Roep BO, Schipper RF, Van der Auwera B, Naipal A, Gorus F, Schuit F & Giphart MJ. TNFa microsatellite polymorphism modulates the risk of IDDM in Caucasians with the high-risk genotype HLA DQA1*0501-DQB1*0201/ DQA1*0301-DQB1*0302. Belgian Diabetes Registry. Diabetes 1997 46 1514-1515.
37. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL & Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999 285 727-729.
38. Dittmar M, Ide M, Wurm M & Kahaly GJ. Early onset of polyglandular failure is associated with HLA-DRB103. European Journal of Endocrinology 2008 159 55-60.
39. Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A & Sanjeevi CB. Association of MHC Class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 2000 43 507-514.
40. Kotsa K, Watson PF & Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clinical Endocrinology 1997 46 551-554.
41. Ostrov DA, Shi W, Schwartz JC, Almo SC & Nathenson SG. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 2000 290 816-819.
42. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Rønningen KS, Guja C, Ionescu-Tîrgovişte C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA & Gough SC. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003 423 506-511.
43. Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, Wang PW, Ban Y, Bednarczuk T, Chistiakova EI, Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu RT, Miyake I, Omrani GH, Pawlak E, Taniyama M, Tozaki T & Ioannidis JP. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 3162-3170.
44. Siminovitch KA. PTPN22 and autoimmune disease. Nature Genetics 2004 36 1248-1249.
45. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D & Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nature Genetics 2004 36 337-338.
46. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, Mc McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ & Gregersen PK. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.American Journal of Human Genetics 2004 75 330-337.
47. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, Chang M, Ramos P, Baechler EC, Batliwalla FM, Novitzke J, Williams AH, Gillett C, Rodine P, Graham RR, Ardlie KG, Gaffney PM, Moser KL, Petri M, Begovich AB, Gregersen PK & Behrens TW. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. American Journal of Human Genetics 2004 75 504-507.
48. Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, Arango A & Martin J. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes and Immunotherapy 2005 6 628-631.
49. Huber A, Menconi F, Corathers S, Jacobson EM & Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocrine Reviews 2008 29 697-725.
50. Dultz G, Matheis N, Dittmar M, Röhrig B, Bender K & Kahaly GJ. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 2009 19 143-148.
51. Dultz G, Dittmar M & Kahaly GJ. Genetics of thyroid autoimmunity - update and clinical relevance. Medizinische Klinik 2009 104 210-219.
52. Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J & Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nature Genetics 1994 8 83-87.
53. Bjorses P, Aaltonen J, Vikman A, Perheentupa J, Ben-Zion G, Chiumello G, Dahl N, Heideman P, Hoorweg-Nijman JJ, Mathivon L, Mullis PE, Pohl M, Ritzen M, Romeo G, Shapiro MS, Smith CS, Solyom J, Zlotogora J & Peltonen L. Genetic homogeneity of autoimmune polyglandular disease type I. American Journal of Human Genetics 1996 59 879-886.
54. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F & Shimizu N. Positional cloning of the APECED gene. Nature Genetics 1997 17 393-398.
55. Pearce SH, Cheetham T, Imrie H, Vaidya B, Barnes ND, Bilous RW, Carr D, Meeran K, Shaw NJ, Smith CS, Toft AD, Williams G & Kendall-Taylor P. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. American Journal of Human Genetics 1998 63 1675-1684.
56. Wang CY, Davoodi-Semiromi A, Huang W, Connor E, Shi JD & She JX. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Human Genetics 1998 103 681-685.
57. Chen QY, Lan MS, She JX & MacLaren NK. The gene responsible for autoimmune polyglandular syndrome type 1 maps to chromosome 21q22.3 in US patients. Journal of Autoimmunity 1998 11 177-183.
58. Heino M, Peterson P, Kudoh J, Shimizu N, Antonarakis SE, Scott HS & Krohn K. APECED mutations in the autoimmue regulator (AIRE) gene. Human Mutation 2001 18 205-211.
59. Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kampe O, Rorsman F, Peltonen L, Ulmanen I & Partanen J. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. Journal of Clinical Endocrinology and Metabolism 2002 87 2568-2574.
60. Dittmar M & Kahaly GJ. Genetics of autoimmune hypoparathyroidism. Clinical Cases in Mineral and Bone Metabolism 2004 1 113-116.
61. Vogel A, Strassburg CP, Obermayer-Straub P, Brabant G & Manns MP. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. Journal of Molecular Medicine 2002 80 201-211.
62. Kumar R, Reddy DV, Unikrishnan AG, Bhadada SK, Agrawal NK & Singh SK. Polyglandular autoimmune endocrinopathy in type 2 diabetes. Journal of the Association of Physicians of India 2004 52 999-1000.
63. Dittmar M & Kahaly GJ. Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up. Journal of Clinical Endocrinology and Metabolism 2003 88 2983-2992.
64. Betterle C. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews 2002 23 327-354.
65. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Smith BR & Furmaniak J. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome. Addison's disease, and premature ovarian failure. Journal of Clinical Endocrinology and Metabolism 1996 81 1871-1876.
66. Bednarek J. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Letters 1992 309 51.
67. Krohn K. Identification by molecular cloning of an autoantigen associated with Addison' disease as steroid 17 α-hydroxylase. Lancet 1992 339 770.
68. Dieterich W. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Medicine 1997 3 797.
69. Devendra D, Franke B, Galloway TS, Horton SJ, Knip M & Wilkin TJ. Distinct idiotypes of insulin autoantibody in autoimmune polyendocrine syndrome type 2 and childhood onset type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 2004 89 5266-5270.
70. Hrdá P, Sterzl I, Matucha P, Korioth F & Kromminga A. HLA antigen expression in autoimmune endocrinopathies. Physiological Research 2004 53 191-197.
71. Kahaly GJ, Förster G, Otto E, Hansen C & Schulz G. Type 1 diabetes as part of the polyglandular autoimmune syndrome. In German. Diabetes Stoffwechsel 1997 6 19-27.
72. Kahaly GJ & Dittmar M. Polyglandular failure syndromes. Harrison's Online Updates. New York: The McGraw-Hill Companies, 2004.
73. Betterle C, Lazzarotto F & Presotto F. Autoimmune polyglandular syndrome type 2: the tip of an iceberg? Clinical and Experimental Immunology 2004 137 225-233.
74. Dittmar M & Kahaly GJ. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity. Thyroid 2005 15 239-250.